Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Gepotidacin	286
Overall Study	STARTED	Nitrofurantoin	94
Overall Study	ITT Population	Gepotidacin	281
Overall Study	ITT Population	Nitrofurantoin	93
Overall Study	Microbiological ITT (Micro-ITT)	Gepotidacin	88
Overall Study	Microbiological ITT (Micro-ITT)	Nitrofurantoin	29
Overall Study	Micro-ITT NTF-S	Gepotidacin	83
Overall Study	Micro-ITT NTF-S	Nitrofurantoin	25
Overall Study	Micro-ITT MDR	Gepotidacin	18
Overall Study	Micro-ITT MDR	Nitrofurantoin	3
Overall Study	Safety	Gepotidacin	281
Overall Study	Safety	Nitrofurantoin	93
Overall Study	COMPLETED	Gepotidacin	279
Overall Study	COMPLETED	Nitrofurantoin	92
Overall Study	NOT COMPLETED	Gepotidacin	7
Overall Study	NOT COMPLETED	Nitrofurantoin	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05630833/flow